Civic Intelligence

Cure First

990EZ • Fiscal year 2023 • EIN 45-4721229

Jan 01, 2023 to Dec 31, 2023 • Filed on Nov 15, 2024

1920 38th Ave ESeattle, WA 98112

(206) 337-8298

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

99th percentile

6.53x

Higher debt load relative to assets than 99% of similar nonprofits.

2023 filings • 501(c)3 • <$500k nonprofits • Source year 2023

Liabilities / Revenue

99th percentile

5.78x

Higher debt load relative to revenue than 99% of similar nonprofits.

2023 filings • 501(c)3 • <$500k nonprofits • Source year 2023

Net Margin

1st percentile

-1127%

Higher net margin than 1% of similar nonprofits.

2023 filings • 501(c)3 • <$500k nonprofits • Source year 2023

Top Officer Pay

78th percentile

$0

Higher top officer pay than 78% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2023 filings • 501(c)3 • <$500k nonprofits • Source year 2023

Asset Growth

3rd percentile

-93%

Faster asset growth than 3% of similar nonprofits.

2023 filings • 501(c)3 • <$500k nonprofits • Annualized from 2022 to 2023

Revenue Growth

9th percentile

-56%

Faster revenue growth than 9% of similar nonprofits.

2023 filings • 501(c)3 • <$500k nonprofits • Annualized from 2022 to 2023

Assets

Flat

$4,745

Flat from 2023

Net Assets

-$26,255

No earlier filing loaded for comparison.

Liabilities

Flat

$31,000

Flat from 2023

Revenue

Flat

$5,359

Flat from 2023

Expenses

Flat

$65,749

Flat from 2023

Net Income

Flat

-$60,390

Flat from 2023

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100K$50K$0-$50KAssets 2013: $24,728Net Assets 2013: $24,7282013Assets 2015: $82,920Liabilities 2015: $4,387Net Assets 2015: $78,5332015Assets 2016: $35,722Net Assets 2016: $35,7222016Assets 2017: $53,926Liabilities 2017: $02017Assets 2018: $17,919Net Assets 2018: $17,9192018Assets 2019: $28,201Net Assets 2019: $28,2012019Assets 2020: $33,374Net Assets 2020: $33,3742020Assets 2021: $46,807Liabilities 2021: $02021Assets 2022: $65,135Liabilities 2022: $31,000Net Assets 2022: $34,1352022Assets 2023: $4,745Liabilities 2023: $31,000Net Assets 2023: -$26,2552023Assets 2023: $4,745Liabilities 2023: $31,0002023

Highlighted filing

2023

Assets$4,745
Liabilities$31,000
Net Assets-$26,255

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$200K$100K$0-$100KRevenue 2013: $16,234Expenses 2013: $6,015Net Income 2013: $10,2192013Revenue 2015: $121,800Expenses 2015: $43,939Net Income 2015: $77,8612015Revenue 2016: $139,136Expenses 2016: $181,947Net Income 2016: -$42,8112016Revenue 2017: $147,311Expenses 2017: $129,107Net Income 2017: $18,2042017Revenue 2018: $55,303Expenses 2018: $91,310Net Income 2018: -$36,0072018Revenue 2019: $33,455Expenses 2019: $23,173Net Income 2019: $10,2822019Revenue 2020: $12,259Expenses 2020: $7,086Net Income 2020: $5,1732020Revenue 2021: $14,724Expenses 2021: $1,291Net Income 2021: $13,4332021Revenue 2022: $12,135Expenses 2022: $24,807Net Income 2022: -$12,6722022Revenue 2023: $5,359Expenses 2023: $65,749Net Income 2023: -$60,3902023Revenue 2023: $5,359Expenses 2023: $65,749Net Income 2023: -$60,3902023

Highlighted filing

2023

Revenue$5,359
Expenses$65,749
Net Income-$60,390
Jump To
Filing Snapshot
Filing Period
Jan 1, 2023 to Dec 31, 2023
Signed
Nov 15, 2024
Return Version
2023v5.1
Gross Receipts
$5,359
Mission and Program Overview

Mission

Cure first mission is to accelerate discovery of targeted and less toxic treatment for cancer using innovative technologies.

Program Services

DescriptionGrantsExpenses
CURE FIRST MISSION IS TO ACCELERATE DISCOVERY OF TARGETED AND LESS TOXIC TREATMENT FOR CANCER USING INNOVATIVE TECHNOLOGIES.-$63,017
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
PAT GRAY PHDDirector-$0--
SANDI EVERLOVEDirector-$0--
CARLA GRANDORI MD PHDPresident-$0--
KAREN SPRATT PHDTreasurer-$0--
JEFF LEEMDSecretary-$0--
Filing and Contact Details

Filer

Filer Name
Cure First
EIN
45-4721229
Phone
2063378298
Address
1920 38TH AVE E, SEATTLE, WA 98112

Signing Officer

Name
Carla Grandori Md Phd
Title
Director
Signed
2024-11-15
Discuss with paid preparer
Yes

Preparer

Firm
Visse & Company CPAs
Address
610 Market Street Suite 200, Kirkland, WA 98033
Preparer
Michael a Visse
Phone
4254544880
Supplemental Narrative

Additional Explanations

Other Expenses.1

Research $63017

Other Expenses.2

WEBSITE EXP $374

Other Expenses.3

BANK CHARGE $25

Total Liabilities.1

LOAN PAYABLE - Beginning $31000 LOAN PAYABLE - Ending $31000

Raw XML Appendix169 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0CARLA GRANDORI MD PHD
IRS990EZ/BooksInCareOfDetail/PhoneNum04252708523
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt01920 38TH AVE E
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0SEATTLE
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0WA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd098112
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt065135
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt04745
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt05356
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-60390
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt02333
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt065135
IRS990EZ/Form990TotalAssetsGrp/EOYAmt04745
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GrossReceiptsAmt05359
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt03
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt034135
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0-26255
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt034135
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0-26255
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt00.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt10.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt24.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30.25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt40.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0PAT GRAY PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1SANDI EVERLOVE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2CARLA GRANDORI MD PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3KAREN SPRATT PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4JEFF LEEMD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4Secretary
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt063416
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0CURE FIRST MISSION IS TO ACCELERATE DISCOVERY OF TARGETED AND LESS TOXIC TREATMENT FOR CANCER USING INNOVATIVE TECHNOLOGIES.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0CURE FIRST MISSION IS TO ACCELERATE DISCOVERY OF TARGETED AND LESS TOXIC TREATMENT FOR CANCER USING INNOVATIVE TECHNOLOGIES.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt063017
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt031000
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt031000
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt065749
IRS990EZ/TotalProgramServiceExpensesAmt063017
IRS990EZ/TotalRevenueAmt05359
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0CUREFIRST.ORG
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt05356
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt012133
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt014722
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt012256
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt033450
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt077917
IRS990ScheduleA/GovtFurnSrvcFcltsVl509Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt03
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt02
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt02
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt03
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt05
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt015
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt00
IRS990ScheduleA/GrossReceiptsNonUnrltBusGrp/TotalAmt00
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt03
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt02
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt02
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt03
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt05
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt015
IRS990ScheduleA/InvestmentIncomeCYPct00.00020
IRS990ScheduleA/InvestmentIncomePYPct00.00020
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt00
IRS990ScheduleA/OtherIncome509Grp/TotalAmt00
IRS990ScheduleA/Post1975UBTIGrp/TotalAmt00
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99980
IRS990ScheduleA/PublicSupportPY509Pct00.99980
IRS990ScheduleA/PublicSupportTotal509Amt077917
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft509Grp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt05356
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt012133
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt014722
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt012256
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt033450
IRS990ScheduleA/Total509Grp/TotalAmt077917
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt05359
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt012135
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt014724
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt012259
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt033455
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt077932
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Research $63017
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1WEBSITE EXP $374
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2BANK CHARGE $25
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3LOAN PAYABLE - Beginning $31000 LOAN PAYABLE - Ending $31000
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Other Expenses.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Other Expenses.2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Other Expenses.3
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Total Liabilities.1
ReturnHeader/BuildTS02024-10-15 13:58:12Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0CARLA GRANDORI MD PHD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Director
ReturnHeader/BusinessOfficerGrp/SignatureDt02024-11-15
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CURE FIRST
ReturnHeader/Filer/BusinessNameControlTxt0CURE
ReturnHeader/Filer/EIN0454721229
ReturnHeader/Filer/PhoneNum02063378298
ReturnHeader/Filer/USAddress/AddressLine1Txt01920 38TH AVE E
ReturnHeader/Filer/USAddress/CityNm0SEATTLE
ReturnHeader/Filer/USAddress/StateAbbreviationCd0WA
ReturnHeader/Filer/USAddress/ZIPCd098112
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0true
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0542088418
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Visse & Company CPAs
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0610 Market Street Suite 200
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0Kirkland
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0WA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd098033
ReturnHeader/PreparerPersonGrp/PhoneNum04254544880
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0MICHAEL A VISSE
ReturnHeader/PreparerPersonGrp/SelfEmployedInd0X
ReturnHeader/ReturnTs02024-11-15T14:53:57-08:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02023-01-01
ReturnHeader/TaxPeriodEndDt02023-12-31
ReturnHeader/TaxYr02023

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings